Report Detail

Request for Sample of this report

Medical Devices & Consumables Global RNA Modifying Agents Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

  • RnM4659482
    • |
  • 31 December, 2025
    • |
  • Global
    • |
  • 111 Pages
    • |
  • GIR
    • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global RNA Modifying Agents market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
In this report, we will assess the current U.S. tariff framework alongside international policy adaptations, analyzing their effects on competitive market structures, regional economic dynamics, and supply chain resilience.
RNA modifications refer to various chemical modifications added to RNA molecules, which affect the function, stability and expression of RNA. RNA modifications play an important role in the regulation of gene expression, RNA processing and translation. There are many types of RNA modifications, and the content and function of different types of RNA modifications vary greatly. Among them, methylation modification is one of the main forms of RNA modification. This report mainly studies RNA methylation modification.
This report is a detailed and comprehensive analysis for global RNA Modifying Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global RNA Modifying Agents market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Modifying Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Modifying Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global RNA Modifying Agents market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for RNA Modifying Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global RNA Modifying Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Active Motif, Epigentek, Thermo Fisher Scientific, Merck, Gene Link, abcam, ABclonal, MyBioSource, Beyotime, Hologic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
RNA Modifying Agents market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
N6-Methyladenosine (m6A) Antibody
5-Methylcytosine (5-mC) Antibody
Others
Market segment by Application
Gene Therapy
Cancer Research
Drug Development
Other
Major players covered
Active Motif
Epigentek
Thermo Fisher Scientific
Merck
Gene Link
abcam
ABclonal
MyBioSource
Beyotime
Hologic
Synaptic Systems
Novus Biologicals
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe RNA Modifying Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of RNA Modifying Agents, with price, sales quantity, revenue, and global market share of RNA Modifying Agents from 2020 to 2025.
Chapter 3, the RNA Modifying Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the RNA Modifying Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and RNA Modifying Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of RNA Modifying Agents.
Chapter 14 and 15, to describe RNA Modifying Agents sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global RNA Modifying Agents Consumption Value by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 N6-Methyladenosine (m6A) Antibody
    • 1.3.3 5-Methylcytosine (5-mC) Antibody
    • 1.3.4 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global RNA Modifying Agents Consumption Value by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Gene Therapy
    • 1.4.3 Cancer Research
    • 1.4.4 Drug Development
    • 1.4.5 Other
  • 1.5 Global RNA Modifying Agents Market Size & Forecast
    • 1.5.1 Global RNA Modifying Agents Consumption Value (2020 & 2024 & 2031)
    • 1.5.2 Global RNA Modifying Agents Sales Quantity (2020-2031)
    • 1.5.3 Global RNA Modifying Agents Average Price (2020-2031)

2 Manufacturers Profiles

  • 2.1 Active Motif
    • 2.1.1 Active Motif Details
    • 2.1.2 Active Motif Major Business
    • 2.1.3 Active Motif RNA Modifying Agents Product and Services
    • 2.1.4 Active Motif RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Active Motif Recent Developments/Updates
  • 2.2 Epigentek
    • 2.2.1 Epigentek Details
    • 2.2.2 Epigentek Major Business
    • 2.2.3 Epigentek RNA Modifying Agents Product and Services
    • 2.2.4 Epigentek RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Epigentek Recent Developments/Updates
  • 2.3 Thermo Fisher Scientific
    • 2.3.1 Thermo Fisher Scientific Details
    • 2.3.2 Thermo Fisher Scientific Major Business
    • 2.3.3 Thermo Fisher Scientific RNA Modifying Agents Product and Services
    • 2.3.4 Thermo Fisher Scientific RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Thermo Fisher Scientific Recent Developments/Updates
  • 2.4 Merck
    • 2.4.1 Merck Details
    • 2.4.2 Merck Major Business
    • 2.4.3 Merck RNA Modifying Agents Product and Services
    • 2.4.4 Merck RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Merck Recent Developments/Updates
  • 2.5 Gene Link
    • 2.5.1 Gene Link Details
    • 2.5.2 Gene Link Major Business
    • 2.5.3 Gene Link RNA Modifying Agents Product and Services
    • 2.5.4 Gene Link RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Gene Link Recent Developments/Updates
  • 2.6 abcam
    • 2.6.1 abcam Details
    • 2.6.2 abcam Major Business
    • 2.6.3 abcam RNA Modifying Agents Product and Services
    • 2.6.4 abcam RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 abcam Recent Developments/Updates
  • 2.7 ABclonal
    • 2.7.1 ABclonal Details
    • 2.7.2 ABclonal Major Business
    • 2.7.3 ABclonal RNA Modifying Agents Product and Services
    • 2.7.4 ABclonal RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 ABclonal Recent Developments/Updates
  • 2.8 MyBioSource
    • 2.8.1 MyBioSource Details
    • 2.8.2 MyBioSource Major Business
    • 2.8.3 MyBioSource RNA Modifying Agents Product and Services
    • 2.8.4 MyBioSource RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 MyBioSource Recent Developments/Updates
  • 2.9 Beyotime
    • 2.9.1 Beyotime Details
    • 2.9.2 Beyotime Major Business
    • 2.9.3 Beyotime RNA Modifying Agents Product and Services
    • 2.9.4 Beyotime RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Beyotime Recent Developments/Updates
  • 2.10 Hologic
    • 2.10.1 Hologic Details
    • 2.10.2 Hologic Major Business
    • 2.10.3 Hologic RNA Modifying Agents Product and Services
    • 2.10.4 Hologic RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Hologic Recent Developments/Updates
  • 2.11 Synaptic Systems
    • 2.11.1 Synaptic Systems Details
    • 2.11.2 Synaptic Systems Major Business
    • 2.11.3 Synaptic Systems RNA Modifying Agents Product and Services
    • 2.11.4 Synaptic Systems RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Synaptic Systems Recent Developments/Updates
  • 2.12 Novus Biologicals
    • 2.12.1 Novus Biologicals Details
    • 2.12.2 Novus Biologicals Major Business
    • 2.12.3 Novus Biologicals RNA Modifying Agents Product and Services
    • 2.12.4 Novus Biologicals RNA Modifying Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Novus Biologicals Recent Developments/Updates

3 Competitive Environment: RNA Modifying Agents by Manufacturer

  • 3.1 Global RNA Modifying Agents Sales Quantity by Manufacturer (2020-2025)
  • 3.2 Global RNA Modifying Agents Revenue by Manufacturer (2020-2025)
  • 3.3 Global RNA Modifying Agents Average Price by Manufacturer (2020-2025)
  • 3.4 Market Share Analysis (2024)
    • 3.4.1 Producer Shipments of RNA Modifying Agents by Manufacturer Revenue ($MM) and Market Share (%): 2024
    • 3.4.2 Top 3 RNA Modifying Agents Manufacturer Market Share in 2024
    • 3.4.3 Top 6 RNA Modifying Agents Manufacturer Market Share in 2024
  • 3.5 RNA Modifying Agents Market: Overall Company Footprint Analysis
    • 3.5.1 RNA Modifying Agents Market: Region Footprint
    • 3.5.2 RNA Modifying Agents Market: Company Product Type Footprint
    • 3.5.3 RNA Modifying Agents Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global RNA Modifying Agents Market Size by Region
    • 4.1.1 Global RNA Modifying Agents Sales Quantity by Region (2020-2031)
    • 4.1.2 Global RNA Modifying Agents Consumption Value by Region (2020-2031)
    • 4.1.3 Global RNA Modifying Agents Average Price by Region (2020-2031)
  • 4.2 North America RNA Modifying Agents Consumption Value (2020-2031)
  • 4.3 Europe RNA Modifying Agents Consumption Value (2020-2031)
  • 4.4 Asia-Pacific RNA Modifying Agents Consumption Value (2020-2031)
  • 4.5 South America RNA Modifying Agents Consumption Value (2020-2031)
  • 4.6 Middle East & Africa RNA Modifying Agents Consumption Value (2020-2031)

5 Market Segment by Type

  • 5.1 Global RNA Modifying Agents Sales Quantity by Type (2020-2031)
  • 5.2 Global RNA Modifying Agents Consumption Value by Type (2020-2031)
  • 5.3 Global RNA Modifying Agents Average Price by Type (2020-2031)

6 Market Segment by Application

  • 6.1 Global RNA Modifying Agents Sales Quantity by Application (2020-2031)
  • 6.2 Global RNA Modifying Agents Consumption Value by Application (2020-2031)
  • 6.3 Global RNA Modifying Agents Average Price by Application (2020-2031)

7 North America

  • 7.1 North America RNA Modifying Agents Sales Quantity by Type (2020-2031)
  • 7.2 North America RNA Modifying Agents Sales Quantity by Application (2020-2031)
  • 7.3 North America RNA Modifying Agents Market Size by Country
    • 7.3.1 North America RNA Modifying Agents Sales Quantity by Country (2020-2031)
    • 7.3.2 North America RNA Modifying Agents Consumption Value by Country (2020-2031)
    • 7.3.3 United States Market Size and Forecast (2020-2031)
    • 7.3.4 Canada Market Size and Forecast (2020-2031)
    • 7.3.5 Mexico Market Size and Forecast (2020-2031)

8 Europe

  • 8.1 Europe RNA Modifying Agents Sales Quantity by Type (2020-2031)
  • 8.2 Europe RNA Modifying Agents Sales Quantity by Application (2020-2031)
  • 8.3 Europe RNA Modifying Agents Market Size by Country
    • 8.3.1 Europe RNA Modifying Agents Sales Quantity by Country (2020-2031)
    • 8.3.2 Europe RNA Modifying Agents Consumption Value by Country (2020-2031)
    • 8.3.3 Germany Market Size and Forecast (2020-2031)
    • 8.3.4 France Market Size and Forecast (2020-2031)
    • 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
    • 8.3.6 Russia Market Size and Forecast (2020-2031)
    • 8.3.7 Italy Market Size and Forecast (2020-2031)

9 Asia-Pacific

  • 9.1 Asia-Pacific RNA Modifying Agents Sales Quantity by Type (2020-2031)
  • 9.2 Asia-Pacific RNA Modifying Agents Sales Quantity by Application (2020-2031)
  • 9.3 Asia-Pacific RNA Modifying Agents Market Size by Region
    • 9.3.1 Asia-Pacific RNA Modifying Agents Sales Quantity by Region (2020-2031)
    • 9.3.2 Asia-Pacific RNA Modifying Agents Consumption Value by Region (2020-2031)
    • 9.3.3 China Market Size and Forecast (2020-2031)
    • 9.3.4 Japan Market Size and Forecast (2020-2031)
    • 9.3.5 South Korea Market Size and Forecast (2020-2031)
    • 9.3.6 India Market Size and Forecast (2020-2031)
    • 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
    • 9.3.8 Australia Market Size and Forecast (2020-2031)

10 South America

  • 10.1 South America RNA Modifying Agents Sales Quantity by Type (2020-2031)
  • 10.2 South America RNA Modifying Agents Sales Quantity by Application (2020-2031)
  • 10.3 South America RNA Modifying Agents Market Size by Country
    • 10.3.1 South America RNA Modifying Agents Sales Quantity by Country (2020-2031)
    • 10.3.2 South America RNA Modifying Agents Consumption Value by Country (2020-2031)
    • 10.3.3 Brazil Market Size and Forecast (2020-2031)
    • 10.3.4 Argentina Market Size and Forecast (2020-2031)

11 Middle East & Africa

  • 11.1 Middle East & Africa RNA Modifying Agents Sales Quantity by Type (2020-2031)
  • 11.2 Middle East & Africa RNA Modifying Agents Sales Quantity by Application (2020-2031)
  • 11.3 Middle East & Africa RNA Modifying Agents Market Size by Country
    • 11.3.1 Middle East & Africa RNA Modifying Agents Sales Quantity by Country (2020-2031)
    • 11.3.2 Middle East & Africa RNA Modifying Agents Consumption Value by Country (2020-2031)
    • 11.3.3 Turkey Market Size and Forecast (2020-2031)
    • 11.3.4 Egypt Market Size and Forecast (2020-2031)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
    • 11.3.6 South Africa Market Size and Forecast (2020-2031)

12 Market Dynamics

  • 12.1 RNA Modifying Agents Market Drivers
  • 12.2 RNA Modifying Agents Market Restraints
  • 12.3 RNA Modifying Agents Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of RNA Modifying Agents and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of RNA Modifying Agents
  • 13.3 RNA Modifying Agents Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 RNA Modifying Agents Typical Distributors
  • 14.3 RNA Modifying Agents Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on RNA Modifying Agents. Industry analysis & Market Report on RNA Modifying Agents is a syndicated market report, published as Global RNA Modifying Agents Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of RNA Modifying Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo